Insights On Enterprise Solutions

  1. Efficient Solutions Supporting Freezing And Storage Operations In Bulk Drug Manufacturing 8/13/2026

    Practical strategies for reducing handling steps, minimizing product loss risk, and improving operator efficiency in frozen drug substance cold chain operations.

  2. Reducing Risks In Biologics Manufacturing Through Predictive Modeling And PAT 8/12/2026

    Complex biologics development increasingly relies on adaptive, knowledge-driven strategies combining platform methods, targeted customization, high-throughput experimentation, and prior knowledge to accelerate IND readiness.

  3. What Makes ADC Tech Transfers So Difficult? 8/11/2026

    In this opening segment from the Bioprocess Online Live event “Ensuring Successful Technology Transfer In ADC Development,” panelists Sourav Kundu, Ph.D., and Will Olughu, Ph.D., explain how ADC constructs complicate process and knowledge transfers compared to traditional biologics.

  4. Measuring The Success Of A Technology Transfer 8/11/2026

    In this segment from the Bioprocess Online Live event “Ensuring Successful Technology Transfer In ADC Development,” panelists Sourav Kundu, Ph.D., and Will Olughu, Ph.D., share their thoughts on what constitutes a successful tech transfer in ADC development and opine on the most common mistakes they’ve witnessed.

  5. Transferring Analytical Methods In ADC Development 8/11/2026

    In this closing segment from the Bioprocess Online Live event “Ensuring Successful Technology Transfer In ADC Development,” panelists Sourav Kundu, Ph.D., and Will Olughu, Ph.D., discuss the transfer of analytical methods and importance of functionality assays in ADC development, as well as the traits of good CDMO partners.

  6. The Risk Of Losing Tacit Knowledge In An ADC Tech Transfer 8/11/2026

    In this segment from the Bioprocess Online Live event “Ensuring Successful Technology Transfer In ADC Development,” panelists Sourav Kundu, Ph.D., and Will Olughu, Ph.D., respond to audience questions and reflect on poll results  that identified tacit knowledge as the most difficult aspect of a process to transfer effectively.

  7. The Unique Challenge Of Transferring Conjugation Methods 8/11/2026

    In this segment from the Bioprocess Online Live event “Ensuring Successful Technology Transfer In ADC Development,” panelists Sourav Kundu, Ph.D., and Will Olughu, Ph.D., share their thoughts on the most difficult aspects of an ADC tech transfer, agreeing that conjugation methods rank near the top of the list.

  8. The Challenge Transferring Proprietary ADC Technology 8/11/2026

    In this segment from the Bioprocess Online Live event “Ensuring Successful Technology Transfer In ADC Development,” panelists Sourav Kundu, Ph.D., and Will Olughu, Ph.D., discuss the underestimated parts of a technology transfer, which includes intimate process knowledge.

  9. Plotting The Timeline For A Tech Transfer In ADC Development 8/11/2026

    In this segment from the Bioprocess Online Live event “Ensuring Successful Technology Transfer In ADC Development,” panelists Sourav Kundu, Ph.D., and Will Olughu, Ph.D., answer an audience question about when to start planning a technology transfer and what to prioritize when doing so. “The more bespoke the molecule, the longer it will take,” says Olughu.

  10. In Silico Immunogenicity Assessment For Peptides 8/11/2026

    Predict immunogenic risks in peptides with unnatural amino acids using in silico workflows. High-accuracy simulations predict HLA binding to accelerate safety assessments and regulatory approvals.